AORT vs BBNX

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 05, 2026

AORT

37.8
AI Score
VS
BBNX Wins

BBNX

49.6
AI Score

Investment Advisor Scores

AORT

38score
Recommendation
AVOID NEW MONEY

BBNX

50score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric AORT BBNX Winner
Forward P/E 35.461 0 Tie
PEG Ratio 181.5 0 Tie
Revenue Growth 11.3% 30.3% BBNX
Earnings Growth 0.0% 0.0% Tie
Tradestie Score 37.8/100 49.6/100 BBNX
Profit Margin -0.7% -65.3% AORT
Beta 1.00 1.00 Tie
AI Recommendation AVOID NEW MONEY HOLD BBNX

Relative Price Performance (Last 90 Days)

AORT 1M: -6.1% · 3M: -28.5% BBNX 1M: -7.5% · 3M: -4.7%

Current Technical Phase

AORT

Markdown
Sell / avoid

Price below a falling SMA50 (slope -7.5%), weak momentum, RSI 40

RSI (14): 39.5 · Price: $20.47

BBNX

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 46

RSI (14): 45.6 · Price: $16.52

Fundamentals Snapshot

Metric AORT BBNX
Market Cap — —
Forward P/E 39.4 -7.6
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth 0.1% 0.3%
Gross Margin 0.6% 0.6%
Operating Margin 0.0% -0.7%
EPS -0.36 -1.83
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, BBNX is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.